TCDD and other AhR ligands have been shown to upregulate expression of the cyclin-dependent kinase (CDK) inhibitor p27kip1 resulting in G1 arrest and growth inhibition of hepatoma cells [4]. This evidence concerns the gene CDKN1B and hepatocellular carcinoma.